Curcumin Modulates DNA Methylation in Colorectal Cancer Cells

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Link, Alexander ^a,b   Balaguer, Francesc ^a,c   Shen, Yan ^a   Lozano, Juan Jose ^c   Leung, Hon Chiu E ^d   Boland, C Richard ^a   Goel, Ajay ^a  

^a BAYLOR RESEARCH INSTITUTE   (United States)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY OF BARCELONA   (Spain)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CURCUMIN; TRICHOSTATIN A;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; DOWN REGULATION; DRUG TARGETING; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROMOTER REGION; PYROSEQUENCING; QUANTITATIVE STUDY; UPREGULATION;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; CPG ISLANDS; CURCUMIN; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENETIC LOCI; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84874537453     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057709     Document Type: Article

References (48)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Feinberg AP, Ohlsson R, Henikoff S, (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7: 21-33.
3. Feinberg AP, (2008) Epigenetics at the epicenter of modern medicine. JAMA 299: 1345-1350.
4. Wong JJ, Hawkins NJ, Ward RL, (2007) Colorectal cancer: a model for epigenetic tumorigenesis. Gut 56: 140-148.
5. Doll R, Peto R, (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66: 1191-1308.
6. Peto J, (2001) Cancer epidemiology in the last century and the next decade. Nature 411: 390-395.
7. Suzuki K, Suzuki I, Leodolter A, Alonso S, Horiuchi S, et al. (2006) Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9: 199-207.
8. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, et al. (2003) Induction of tumors in mice by genomic hypomethylation. Science 300: 489-492.
9. Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, et al. (2007) The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132: 127-138.
10. Karpf AR, Matsui S, (2005) Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res 65: 8635-8639.
11. Rodriguez J, Frigola J, Vendrell E, Risques RA, Fraga MF, et al. (2006) Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res 66: 8462-9468.
12. Issa JP, Baylin SB, Belinsky SA, (1996) Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. Cancer Res 56: 3655-3658.
13. Issa JP, (2007) DNA methylation as a therapeutic target in cancer. Clin Cancer Res 13: 1634-1637.
14. Laird PW, (2003) The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266.
15. Link A, Balaguer F, Goel A, (2010) Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol 80: 1771-1792.
16. Nagasaka T, Goel A, Notohara K, Takahata T, Sasamoto H, et al. (2008) Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis. Int J Cancer 122: 2429-2436.
17. Sporn MB, Suh N, (2002) Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer 2: 537-543.
18. Ghoshal K, Datta J, Majumder S, Bai S, Kutay H, et al. (2005) 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Mol Cell Biol 25: 4727-4741.
19. Patel K, Dickson J, Din S, Macleod K, Jodrell D, et al. (2010) Targeting of 5-aza-2′-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme. Nucleic Acids Res 38: 4313-4324.
20. Schermelleh L, Spada F, Easwaran HP, Zolghadr K, Margot JB, et al. (2005) Trapped in action: direct visualization of DNA methyltransferase activity in living cells. Nat Methods 2: 751-756.
21. Eads CA, Nickel AE, Laird PW, (2002) Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic Mice. Cancer Res 62: 1296-1299.
22. Goel A, Jhurani S, Aggarwal BB, (2008) Multi-targeted therapy by curcumin: how spicy is it? Mol Nutr Food Res 52: 1010-1030.
23. Davis CD, Uthus EO, (2002) Dietary selenite and azadeoxycytidine treatments affect dimethylhydrazine-induced aberrant crypt formation in rat colon and DNA methylation in HT-29 cells. J Nutr 132: 292-297.
24. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, et al. (2003) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63: 7563-7570.
25. Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, et al. (2005) Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 11: 7033-7041.
26. Majid S, Dar AA, Shahryari V, Hirata H, Ahmad A, et al. (2010) Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer 116: 66-76.
27. Chuang JC, Yoo CB, Kwan JM, Li TW, Liang G, et al. (2005) Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine. Mol Cancer Ther 4: 1515-1520.
28. Stresemann C, Brueckner B, Musch T, Stopper H, Lyko F, (2006) Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res 66: 2794-2800.
29. Goel A, Kunnumakkara AB, Aggarwal BB, (2008) Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 75: 787-809.
30. Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, et al. (2004) Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 279: 51163-51171.
31. Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, et al. (2008) The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 118: 868-878.
32. Jha AK, Nikbakht M, Parashar G, Shrivastava A, Capalash N, et al. (2010) Reversal of hypermethylation and reactivation of the RARbeta2 gene by natural compounds in cervical cancer cell lines. Folia Biol (Praha) 56: 195-200.
33. Kuck D, Singh N, Lyko F, Medina-Franco JL, (2010) Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation. Bioorg Med Chem 18: 822-829.
34. Liu Z, Xie Z, Jones W, Pavlovicz RE, Liu S, et al. (2009) Curcumin is a potent DNA hypomethylation agent. Bioorg Med Chem Lett 19: 706-709.
35. Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, et al. (2010) Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res 70: 6609-6618.
36. Gunderson KL, (2009) Whole-genome genotyping on bead arrays. Methods Mol Biol 529: 197-213.
37. Shen Y, Takahashi M, Byun HM, Link A, Sharma N, et al. (2012) Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells. Cancer Biol Ther 13: 542-552.
38. Kristensen LS, Mikeska T, Krypuy M, Dobrovic A, (2008) Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection. Nucleic Acids Res 36: e42.
39. Link A, Shin SK, Nagasaka T, Balaguer F, Koi M, et al. (2009) JC virus mediates invasion and migration in colorectal metastasis. PLoS One 4: e8146.
40. Yagi K, Akagi K, Hayashi H, Nagae G, Tsuji S, et al. (2010) Three DNA methylation epigenotypes in human colorectal cancer. Clin Cancer Res 16: 21-33.
41. Figueiredo JC, Grau MV, Wallace K, Levine AJ, Shen L, et al. (2009) Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev 18: 1041-1049.
42. Costello JF, Krzywinski M, Marra MA, (2009) A first look at entire human methylomes. Nat Biotechnol 27: 1130-1132.
43. Yoo CB, Jones PA, (2006) Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 5: 37-50.
44. Shukeir N, Pakneshan P, Chen G, Szyf M, Rabbani SA, (2006) Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Cancer Res 66: 9202-9210.
45. Ateeq B, Unterberger A, Szyf M, Rabbani SA, (2008) Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo. Neoplasia 10: 266-278.
46. Hamm CA, Xie H, Costa FF, Vanin EF, Seftor EA, et al. (2009) Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2′-deoxycytidine results in increased tumorigenicity. PLoS One 4: e8340.
47. Prasanna P, Shack S, Wilson VL, Samid D, (1995) Phenylacetate in chemoprevention: in vitro and in vivo suppression of 5-aza-2′-deoxycytidine-induced carcinogenesis. Clin Cancer Res 1: 865-871.
48. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, et al. (2012) The accessible chromatin landscape of the human genome. Nature 489: 75-82.